Healthcare Device Company Valuation
Who this is for
Medical device founders seeking strategic acquisition or growth equity, large medtech corporate development teams benchmarking bolt-on targets, and medtech venture investors marking positions to market.
What drives value in Healthcare Devices
- FDA clearance or approval status (510(k), PMA, De Novo) and IP protection
- Recurring revenue from disposables, service contracts, or software subscriptions
- Clinical evidence depth and published outcomes data
- Commercial traction: procedure volumes, installed base, and ASP trends
- Sales force infrastructure and GPO/IDN contract coverage
- Pipeline of next-generation products leveraging cleared platform
Valuation methods we use
Commercial-stage medical device companies are valued on revenue multiples (3–8×) and EBITDA multiples (15–25× for high-growth devices). Pre-commercial devices are valued on pipeline-adjusted comparable transaction analysis. This tool is informational only. Output is driven by your inputs and does not constitute a formal appraisal or certified valuation.
Typical metrics and inputs
Recurring revenue %
Share of revenue from disposables, service, or SaaS; recurring revenue commands higher multiples than capital equipment.
ASP trend
Average selling price trajectory; rising ASP signals commercial execution and value capture.
Procedure volume growth
Year-over-year growth in procedures using the device; the leading commercial adoption indicator.
Gross margin
Typically 55–75% for medical devices; higher for software-embedded or disposable-heavy models.
Revenue growth rate
Annual revenue growth; 20–50%+ YoY is expected for premium multiples in medtech.
Example scenarios
FDA-cleared minimally invasive surgical device
A surgical device company with $10 M revenue growing 40%, 65% gross margin, and expanding procedure adoption might be valued at 5–7× revenue by a strategic acquirer.
Software-embedded diagnostic device
A diagnostic device with embedded AI software, $3 M ARR from SaaS subscriptions, and 510(k) clearance might trade at 8–12× revenue.
Frequently asked questions
What multiple does a medical device company sell for?
Commercial-stage devices with strong growth: 4–8× revenue. Profitable medtech platforms: 15–25× EBITDA. Strategic premiums can push these higher for category-defining products.
How much does FDA clearance add to value?
Significant — FDA clearance de-risks the clinical and regulatory path, unlocking commercial adoption. A cleared device is typically valued at 5–10× the value of a pre-cleared device in the same category.
Why does recurring revenue matter for medical devices?
Disposable or software-linked revenue extends customer LTV, reduces revenue volatility, and supports SaaS-like valuation multiples rather than one-time capital equipment multiples.
What do large medtech companies look for in acquisitions?
Technology platform adjacency, strong clinical evidence, GPO/IDN access, and a commercial team that can accelerate with the acquirer's distribution network.
Is this a certified appraisal?
No. This tool provides informational estimates. For formal medtech M&A, engage a healthcare-focused investment banker.
Run your Healthcare Devices valuation
Get a professional-grade valuation report using DCF, comparable companies, precedent transactions, and scenario analysis — for just $9.99.
Join the waitlist →Related industries
Biotech & Pharma
Value a biotech or pharmaceutical company using rNPV, pipeline analysis, and pharma comparable transactions. AI-powered reports for $9.99.
Medical Labs
Value a clinical laboratory, pathology lab, or diagnostic testing company using EBITDA multiples and revenue per accession analysis. Reports for $9.99.
Clinic Rollup / DSO
Value a DSO, optometry rollup, or multi-specialty clinic platform using EBITDA multiples and site-level economics. Reports for $9.99.
Healthcare Services
Value a healthcare services company using EBITDA multiples, revenue per provider, and payer mix analysis. AI-powered reports for $9.99.